A system that combines magnetic resonance imaging guidance with high-intensity focused ultrasound to noninvasively treat pain in cancer patients with bone metastases.
Emerging Technology Reports
The Emerging Technology Report provides regular updates about emerging and potentially disruptive technologies that are likely to have a significant impact in healthcare. This “early warning” report monitors new health technologies from 6 months to 2 years within a regulatory submission and tracks those as they go through clinical trial development and the regulatory approval process.
For each emerging technology, our analysts describe the technology and intended use, its prospects relative to the regulatory process and FDA information, competing technologies, relevant clinical guidelines, high-level look at the evidence such as published abstracts in the medical literature and available meeting abstracts, and available clinical trials.
Elvitegravir (Formerly GS-9137)
An oral integrase inhibitor for the treatment of human immunodeficiency virus infection.
Jetrea® (Ocriplasmin Intravitreal Injection)
Recombinant human microplasmin intravitreal injection for treatment of symptomatic vitreomacular adhesion, including macular hole.
CytoSorb® Blood Filtration Device
A hemoperfusion blood filtration device under investigation for use as an adjunct to current care treatments in patients who develop severe sepsis in the critical care setting.
Solitaire™ Flow Restoration (FR) Intra-Arterial Thrombectomy Device
A fully retrievable, self-expanding, intracranial stent for acute revascularization of large vessel occlusions in patients with ischemic stroke who are ineligible for or who fail intravenous tissue plasminogen activator therapy.
S-ICD® (Subcutaneous Implantable Cardioverter Defibrillator)
An entirely subcutaneous implantable cardioverter defibrillator that does not use transvenous lead wires, proposed to detect and correct life-threatening arrhythmias in selected patients at risk of sudden cardiac death.
Eylea® (Aflibercept Intravitreal Injection, Formerly VEGF Trap-Eye) for Age-Related Macular Degeneration
A recombinant fusion protein for intravitreal injection to treat the wet form of age-related macular degeneration.
Eylea® (Aflibercept Intravitreal Injection, Formerly VEGF Trap-Eye) for Macular Edema Following Central Retinal Vein Occlusion
A recombinant fusion protein for intravitreal injection to treat macular edema following central retinal vein occlusion.
Aubagio® (Teriflunomide)
A once-daily oral therapy for the treatment of relapsing remitting multiple sclerosis.
Xtandi® (Enzalutamide, Formerly MDV3100)
A once-daily, oral, hormonal treatment for metastatic, castration-resistant, prostate cancer in men who have previously received docetaxel.